Weekly Newsletter

Thursday, November 6, 2025

News

AstraZeneca Wins Shareholder Approval for U.S. Direct Listing on the NYSE

The move strengthens AstraZeneca’s global market presence, giving the pharma giant greater access to U.S. investors and deeper capital resources. LONDON — November 3, 2025. In a major step toward expanding its global footprint, AstraZeneca (AZN.L) has received overwhelming shareholder...

Kimberly Clark to Acquire Kenvue in a $48.7 Billion Deal, Creating A Global Health and Wellness Powethouse

The merger brings together two trusted giants—Kimberly-Clark and Kenvue to redefine the future of personal care and consumer health worldwide DALLAS — November 3, 2025. In a game changing move for the health and wellness industry, Kimberly – Clark Corporation...

Healing Hearts: Merck Foundation’s $22 Million Mission to Bridge Gaps in Cardiac Care

Empowering communities across the U.S. with equal access to life-saving heart health services RAHWAY, N.J. — November 4, 2025. Heart disease remains the leading cause of death in the United States, claiming millions of lives every year. But change is...

Oscar Health Expands in Dallas-Fort Worth With Smart, Affordable Plans for 2026

The tech-driven insurer brings $0 virtual care, personalized AI tools, and the first menopause health plan to North Texas residents. DALLAS — November 3, 2025. Oscar Health, Inc. (NYSE: OSCR), a leader in healthcare technology and insurance innovation, has announced...

Innovators

Insights

The Importance of Clear Communication in Patient Monitoring Technologies

Patient monitoring systems have become an important tool to improve healthcare. The advancement of technologies allows to perform activities that were unthinkable till recently. Remote data access allows health care professionals to closely monitor patients and react in real-time. These...

Monitoring for adverse reactions with GLP-1 agonists

The recent uptick of prescribing glucagon-like peptide 1 (GLP-1) agonists has created market shortages due to unprecedented demands. Liraglutide, dulaglutide, tirzepatide and semaglutide are indicated to improve glycemic control in type 2 diabetes mellitus. In addition, tirzepatide and semaglutide...

How Tech-Enabled Remote Patient Monitoring is Transforming Care Delivery Across the Continuum

Twenty years ago, when we founded our healthcare IT-focused public relations and marketing firm, patient monitoring did not typically leave the four walls of the hospital. Our clients at the time were among the first to design software and...

A new era for the medical sector in 2030

The health sector has always been primordial to me. Not only because it is more than essential, vital for human beings, but also because many economic, societal and technological challenges of the future arise directly from this area. Which...